Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 30;11(7):1930.
doi: 10.3390/jcm11071930.

Cerebral Tissue Oxygen Saturation Is Enhanced in Patients following Transcatheter Aortic Valve Implantation: A Retrospective Study

Affiliations

Cerebral Tissue Oxygen Saturation Is Enhanced in Patients following Transcatheter Aortic Valve Implantation: A Retrospective Study

Götz Schmidt et al. J Clin Med. .

Abstract

Transcatheter aortic valve implantation (TAVI) has emerged as an alternative to surgical aortic valve replacement. The aim of this study was to evaluate whether a relevant alteration in cerebral tissue oxygen saturation (rSO2) could be detected following TAVI. Retrospective data analysis included 275 patients undergoing TAVI between October 2016 and December 2020. Overall, rSO2 significantly increased following TAVI (64.6 ± 10% vs. 68.1 ± 10%, p < 0.01). However, a significant rise was only observed in patients with a preoperative rSO2 < 60%. Of the hemodynamic confounders studied, hemoglobin, mean arterial pressure and blood pH were lowered, while central venous pressure and arterial partial pressure of carbon dioxide (PaCO2) were slightly elevated (PaCO2: 39 (36−43) mmHg vs. 42 (37−47) mmHg, p = 0.03; pH: 7.41 (7.3−7.4) vs. 7.36 (7.3−7.4), p < 0.01). Multivariate linear regression modeling identified only hemoglobin as a predictor of altered rSO2. Patients with a EuroScore II above 4% and an extended ICU stay were found to have lower rSO2, while no difference was observed in patients with postoperative delirium or between the implanted valve types. Further prospective studies that eliminate differences in potential confounding variables are necessary to confirm the rise in rSO2. Future research should provide more information on the value of cerebral oximetry for identifying high-risk patients who will require further clinical interventions in the setting of the TAVI procedure.

Keywords: NIRS; TAVI; cardiac surgery; cerebral oximetry; near-infrared spectroscopy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study flowchart. TAVI = transcatheter aortic valve implantation.
Figure 2
Figure 2
(a) Cerebral rSO2 was enhanced after TAVI. (b) Analysis stratified by preoperative values revealed a significant increase only in patients with preoperative rSO2 ≤ 50% and 51–60%. **: p < 0.01; ***: p < 0.001; ns: not significant; rSO2 = regional cerebral oxygen saturation.

References

    1. Carabello B.A., Paulus W.J. Aortic stenosis. Lancet. 2009;373:956–966. doi: 10.1016/S0140-6736(09)60211-7. - DOI - PubMed
    1. Chiam P.T., Ewe S.H. The expanding indications of transcatheter aortic valve implantation. Futur. Cardiol. 2016;12:209–219. doi: 10.2217/fca.15.86. - DOI - PubMed
    1. Marsh K., Hawken N., Brookes E., Kuehn C., Liden B. Patient-centered benefit-risk analysis of transcatheter aortic valve replacement. F1000Research. 2021;8:394. doi: 10.12688/f1000research.18796.5. - DOI - PMC - PubMed
    1. Siemieniuk R.A., Agoritsas T., Manja V., Devji T., Chang Y., Bala M.M., Thabane L., Guyatt G.H. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: Systematic review and meta-analysis. BMJ. 2016;354:i5130. doi: 10.1136/bmj.i5130. - DOI - PMC - PubMed
    1. Baron S.J., Wang K., House J.A., Magnuson E.A., Reynolds M.R., Makkar R., Herrmann H.C., Kodali S., Thourani V.H., Kapadia S., et al. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk. Circulation. 2019;139:877–888. doi: 10.1161/CIRCULATIONAHA.118.035236. - DOI - PubMed

LinkOut - more resources